Perinatal depression and anxiety.
Journal
The Nurse practitioner
ISSN: 1538-8662
Titre abrégé: Nurse Pract
Pays: United States
ID NLM: 7603663
Informations de publication
Date de publication:
01 Aug 2024
01 Aug 2024
Historique:
medline:
26
7
2024
pubmed:
26
7
2024
entrez:
25
7
2024
Statut:
ppublish
Résumé
Perinatal depression (PND) and perinatal anxiety are common conditions that can arise during or after pregnancy and can have a major impact on patients and their families. A potential outcome of PND includes death by suicide, a leading cause of maternal mortality. This article provides an overview of these conditions, including discussion of neurobiology, risk factors, warning signs for individuals at risk for suicide and/or infant harm, and relevant screening tools. Considerations for psychotherapy and pharmacotherapy are highlighted, and an overview of neuroactive steroid gamma-aminobutyric acid A receptor positive allosteric modulators, a newer pharmacologic treatment option for postpartum depression, is provided.
Identifiants
pubmed: 39049151
doi: 10.1097/01.NPR.0000000000000188
pii: 00006205-202408000-00008
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
29-33Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. American Psychiatric Association; 2022.
Trost S, Beauregard J, Chandra G, et alPregnancy-related deaths: data from maternal mortality review committees in 36 US states, 2017-2019. www.cdc.gov/reproductivehealth/maternal-mortality.
Falek I, Acri M, Dominguez J, et al. Management of depression during the perinatal period: state of the evidence. Int J Ment Health Syst. 2021;16(1):21.
Bayrampour H, Vinturache A, Hetherington E, Lorenzetti DL, Tough S. Risk factors for antenatal anxiety: a systematic review of the literature. J Reprod Infant Psychol. 2018;36(5):476–503.
World Health Organization. Maternal Mental Health. 2019. www.who.int.
Cutler AJ, Mattingly GW, Maletic V. Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Transl Psychiatry. 2023;13(1):228.
The Columbia Lighthouse Project. The Columbia Protocol. https://cssrs.columbia.edu/wp-content/uploads/Columbia_Protocol.pdf.
Dazzi T, Gribble R, Wessely S, Fear NT. Does asking about suicide and related behaviours induce suicidal ideation? What is the evidence. Psychol Med. 2014;44(16):3361–3363.
O'Connor E, Senger CA, Henninger ML, Coppola E, Gaynes BN. Interventions to prevent perinatal depression: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;321(6):588–601.
Howard LM, Khalifeh H. Perinatal mental health: a review of progress and challenges. World Psychiatry. 2020;19(3):313–327.
Nynas J, Narang P, Kolikonda MK, Lippmann S. Depression and anxiety following early pregnancy loss: recommendations for primary care providers. Prim Care Companion CNS Disord. 2015;17(1). doi:10.4088/PCC.14r01721.
Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782–786.
McIntyre RS, Patel MD, Masand PS, et al. The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder. Curr Med Res Opin. 2021;37(1):135–144.
ACOG. Treatment and management of mental health conditions during pregnancy and postpartum. ACOG Clinical Practice Guideline No. 5. Obstet Gynecol. 2023;141(6):1262–1288.
Viswanathan M, Middleton JC, Stuebe A, et al. Maternal, fetal, and child outcomes of mental health treatments in women: a systematic review of perinatal pharmacologic interventions. Comparative Effectiveness Review No. 236. Rockville, MD: AHRQ; 2021.
Scrandis DA. Antidepressant use in breastfeeding women. Nurse Pract. 2018;43(10):18–21.
Zulresso. Package insert. Sage Therapeutics, Inc. 2022.
Zurzuvae. Package insert. Biogen MA Inc. 2023.
Walkery A, Leader LD, Cooke E, VandenBerg A. Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders. Drug Des Devel Ther. 2021;15:3017–3026. Published 2021 Jul 9. doi:10.2147/DDDT.S240856
Postpartum Support International. www.postpartum.net/. Accessed April 8, 2024.
National Institute of Child Health and Human Development. Drugs and Lactation Database (LactMed®). www.ncbi.nlm.nih.gov/books/NBK501922/. Accessed April 8, 2024.